ADIAL PHARMACEUTICALS, INC. (ADIL): auditor change — Adial Pharmaceuticals replaces auditor Marcum with CBIZ CPAs effective April 28, 2025

ADIAL PHARMACEUTICALS, INC.

Marcum resigned as independent auditor; CBIZ CPAs engaged for FY 2025, effective immediately.
Marcum's reports for FY 2024 and 2023 included a going-concern explanatory paragraph but no adverse opinion.
No disagreements with Marcum; previously reported material weaknesses in internal controls continue.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marcum LLP resigned as auditor of ADIAL PHARMACEUTICALS, INC..

Action: resignation
Auditor: Marcum LLP

Exact text from the filing

On April 28, 2025, Marcum resigned as the Company’s independent registered public accounting firm, and CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025, effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ADIAL PHARMACEUTICALS, INC. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

On April 28, 2025, Marcum resigned as the Company’s independent registered public accounting firm, and CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025, effective immediately.

View on SEC.gov

20 auditor changes filed in the last 30 days. Browse all auditor changes →

ADIAL PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-25-038442

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.